Remodulin 10 MG/ML Injectable Solution

RxCUI: 352214
RxNorm name: Remodulin 10 MG/ML Injectable Solution
Display name: Remodulin 10 MG/ML Injectable Solution
Full name: Remodulin 10 MG/ML Injectable Solution
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Remodulin	TREPROSTINIL	United Therapeutics Corporation	6c80bb38-e8db-4138-9f0d-dbbf9c673185	2026-07-02	Warnings, Adverse reactions	Exact identifier rxcui: 352214

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6c80bb38-e8db-4138-9f0d-dbbf9c673185	Remodulin 10 MG/ML Injectable Solution [PSN] · treprostinil 10 MG/ML Injectable Solution [Remodulin] [SBD] · Remodulin 10 MG/ML Injectable Solution [SY]	3	33	These highlights do not include all the information needed to use REMODULIN safely and effectively. See full prescribing information for REMODULIN. REMODULIN ® (treprostinil) Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002	20250718